Prestige Consumer Healthcare Inc.
NYSE:PBHMedical - Distribution
+$0.23 today
- Market cap
- $2.40B
- Beta
- 0.35
- P/E (TTM)
- 11.6
- EPS (TTM)
- $4.01
Volume 0.62M
Average 0.67M
PBH Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Prestige Consumer Healthcare Inc.NYSE: PBH
Cash & Equivalents · Q1 FY2027 · quarter ended Jun 2026
Cash & equivalents falls 36.1% from a year ago
Cash & equivalents stood at $89.13M at the end of Q1 FY2027, down 36.1% from a year earlier and up 39.5% from the prior quarter. Over 3 fiscal years it compounded at +3.0% a year.
Context
- Cash & equivalents amounted to 2.0% of total assets at the end of Q1 FY2027, down 2.1 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -36.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2026
- 63.87M USD
- Year-over-year change
- -34.8%
- 4-year CAGR
- +23.8%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 63.87M | -34.8% |
| FY2025 | 2025-03-31 | 97.88M | +110.6% |
| FY2024 | 2024-03-31 | 46.47M | -20.6% |
| FY2023 | 2023-03-31 | 58.49M | +115.2% |
| FY2022 | 2022-03-31 | 27.19M | — |
Cash & Equivalents vs competitors
How PBH compares with its peers on the latest reported figures
- PBH's Jun 2026 cash & equivalents of $89.13M is the 9th highest of the 11 companies compared; the peer median is $355.25M.
- Its year-over-year change of -36.1% is the 10th highest of 11, against a peer median of -4.6%.
- Cash & equivalents amounts to 2.0% of total assets for PBH, versus a peer median of 19.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $755.86M | +30.2% | +33.5% | 65.9% | |
| Jun 2026 | $607.52M | -17.0% | -12.3% | 56.5% | |
| Sep 2026 | $563.5M | -12.8% | +43.7% | 20.8% | |
| Sep 2026 | $460.7M | +65.2% | +4.7% | 27.4% | |
| Jun 2026 | $412.2M | +5.7% | +11.3% | 27.7% | |
| Jun 2026 | $298.3M | -0.6% | +13.8% | 7.5% | |
| Mar 2026 | $139.91M | -8.7% | +23.8% | 17.5% | |
IRONDisc Medicine, Inc. | Sep 2026 | $89.98M | -36.0% | -22.3% | 12.9% |
| Jun 2026 | $89.13M | -36.1% | +3.0% | 2.0% | |
CONConcentra Group Holdings Parent, Inc. | Sep 2026 | $85.82M | +71.8% | +28.5% | 2.8% |
HTFLHeartflow, Inc. Common Stock | Sep 2026 | $31.65M | -89.1% | — | 8.9% |
| Peer median (excluding PBH) | $355.25M | -4.6% | +13.8% | 19.1% | |
Competitors are the stored peer set for PBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 27.19M | 58.49M | 46.47M | 97.88M | 63.87M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 139.33M | 167.02M | 176.78M | 194.29M | 191.92M |
| Inventory | 120.34M | 162.12M | 138.72M | 147.71M | 159.13M |
| Other Current Assets | 0 | 4.12M | 13.08M | 8.44M | 16.56M |
| Total Current Assets | 293.27M | 391.74M | 375.04M | 448.33M | 431.48M |
| Property, Plant & Equipment (Net) | 98.53M | 89.54M | 89.33M | 127.84M | 171.25M |
| Goodwill | 578.98M | 527.55M | 527.73M | 527.43M | 581.11M |
| Intangible Assets | 2.7B | 2.34B | 2.32B | 2.3B | 2.3B |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 61.96M |
| Other Non-current Assets | 3.27M | 3.01M | 5.73M | 3.27M | 2.17M |
| Total Non-current Assets | 3.38B | 2.96B | 2.94B | 2.95B | 3.12B |
| Total Assets | 3.67B | 3.35B | 3.32B | 3.4B | 3.55B |
| Account Payables | 55.76M | 62.74M | 38.98M | 18.93M | 22.79M |
| Short-term Debt | 0 | 0 | 0 | 0 | 2.99M |
| Tax Payables | 2.66M | 10.65M | 2.57M | 830K | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 19.59M | 14.29M | 57.13M | 14.21M | 12.13M |
| Total Current Liabilities | 143.42M | 160.72M | 117.05M | 106.62M | 120.92M |
| Long-term Debt | 1.48B | 1.35B | 1.13B | 992.36M | 993.95M |
| Deferred Tax Liabilities | 444.92M | 380.43M | 403.6M | 419.59M | 500.67M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 7.48M | 8.17M | 9.19M | 5.39M | 5.58M |
| Total Non-current Liabilities | 1.95B | 1.75B | 1.55B | 1.46B | 1.54B |
| Total Liabilities | 2.09B | 1.91B | 1.66B | 1.57B | 1.66B |
| Common Stock | 544K | 548K | 555K | 560K | 562K |
| Retained Earnings | 1.21B | 1.13B | 1.34B | 1.56B | 1.75B |
| Accumulated OCI | (19.03M) | (31.56M) | (34.5M) | (37.66M) | (28.37M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.58B | 1.45B | 1.66B | 1.83B | 1.89B |
| Total Debt | 1.51B | 1.37B | 1.14B | 1.04B | 1.05B |
| Net Debt | 1.48B | 1.31B | 1.09B | 946.37M | 981.56M |
Prestige Consumer Healthcare Inc.
NYSE:PBH
Intrinsic Alpha fair value
Locked
Current Price
$50.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.